// App-Quantinova.ai

PB0305 : Method and laboratory specific clinical cut-offs support appropriate interpretation of ADAMTS13 activity assays

Researchers

Presenter

  • S. MacDonald

Principal Investigators

  • P. Murphy

  • C. Downey

  • P. Baker

  • E. Foxton

  • C. Lawrence

  • A. Ali

  • V. Jenkins

  • E. Vilar

  • M. Besser

  • E. Symington

  • M. Robinson

  • M. Desborough

  • W. Thomas

  • J. Yong

  • T. Dutt

Medical Centers

  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

  • THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST, Newcastle, England, United Kingdom

  • Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom

  • Aintree University Hospital NHS Foundation Trust, Liverpool, England, United Kingdom

  • Oxford University Hospitals, Oxford, England, United Kingdom

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Glasgow Royal Infirmary, Glasgow, United Kingdom

  • Edinburgh Royal Infirmary, Edinburgh, United Kingdom

  • Cardiff and Vale University Health Board, Cardiff, Wales, United Kingdom

  • University of Hertfordshire, Hatfield, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved